Author:
Menzel D.,Levi M.,Dooijewaard G.,Peters M.,ten Cate J. W.
Publisher
Springer Science and Business Media LLC
Subject
Hematology,General Medicine
Reference34 articles.
1. Aunsholt NA, Ahlbom G, Steffensen G, Glud T (1992) Fibrinolytic capacity in hemodialysis patients treated with recombinant human erythropoietin. Nephron 62:284–288
2. Bergstein JM, Kuederli U, Bang NU (1982) Plasma inhibitor of glomerular fibrinolysis in the hemolytic-uremic syndrome. Am J Med 73:322–327
3. Bergstein JM, Riley M, Bang NU (1992) Role of plasminogen-activator inhibitor type 1 in the pathogenesis and outcome of the hemolytic-uremic syndrome. N Engl J Med 1992:327:755–759
4. Binnema DJ, van Iersel IL, Dooijewaard G (1986) Quantitation of urokinase antigen in plasma and culture media by use of an ELISA. Thromb Res 43:569–577
5. Blasi F, Vassali J-D, Danø K (1987) Urokinase-type plasminogen activator: proenzyme, receptor and inhibitors. J Cell Biol 104:801–804
Cited by
17 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献